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Abstract
Phytoestrogens are natural compounds found in various plant species and they have the 
ability to bind to the estrogenic receptors, exerting agonist and/or antagonist effects. The 
main classes of phytoestrogens are isoflavones, lignans, and coumestranes. Isoflavones 
are plant bioactive nonsteroidal polyphenolic metabolites with antioxidant properties. 
They have a very close structure with 17β-estradiol and possess estrogenic/antiestrogenic 
effects. The main dietary source of isoflavones is soy (Glycine max L.). Other legumes, 
such as red clover (Trifolium pratense L.), alfalfa (Medicago sativa L.), and Genista species, 
have important content in isoflavones, showing nutritional or phytotherapeutic inter-
est. In plants, isoflavones can be found mainly as non-active glycosides which are con-
verted after ingestion, in the corresponding aglycones (e.g., genistein, daidzein) that have 
pharmacological activity. Many studies have demonstrated the benefits of dietary iso-
flavones in menopause and multiple chronic pathologies, including cardiovascular dis-
eases, osteoporosis, and hormonal cancers. Dietary intake of isoflavones is widespread, 
mainly due to the consumption of soybean products. Analytical methods applied for the 
quantification of isoflavones allow both assessment of dietary intake of isoflavones and 
highlighting natural sources with phytotherapeutic potential. Health benefits of isofla-
vones justify the interest for this class of functional food; therefore, further clinical and 
epidemiological studies are required.
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1. Introduction
Phytoestrogens are natural nonsteroidal compounds able to bind to estrogenic receptors and 
have both estrogenic and antiestrogenic activities. They are widespread in the plant kingdom 
being considered ubiquitous. The main classes of phytoestrogens are isoflavones, coumes-
tans, and lignans.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under th  terms of the Creative Commons
Attribution License (http://creativeco mons.org/licen es/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Isoflavones are plant-derived secondary metabolites with a polyphenolic structure and antiox-
idant properties [1]. They pertain to the flavonoid class and are found mostly in plants belong-
ing to Fabaceae family. Soy (Glycine max L.) is the major natural source of isoflavones, and 
the benefits associated with a soy diet occur mostly because of these phytochemicals. Other 
natural sources of isoflavones are red clover (Trifolium pratense L.), alfalfa (Medicago sativa L.), 
and species of the genus Genista. All of these plants present phytotherapeutic and nutraceuti-
cal significance, and their by-products, herbal teas, and food supplements are often used.
Several epidemiological studies have demonstrated the benefits of dietary isoflavones in 
menopause and multiple chronic pathologies, including cardiovascular diseases, osteoporo-
sis, and hormonal cancers. The main mechanisms of action of isoflavones, their benefits to 
human health, and the factors involved in the modulation of their bioactivity are shown in 
this chapter. Moreover, the analytical methods used for their quantification in plant and food 
samples are introduced. These are very important methods to evaluate the human exposure 
to isoflavones and also to assess the optimum intake for human well-being.
2. Characteristics of isoflavones
2.1. Chemistry and metabolism of isoflavones
Isoflavones (IFs) are yellow pigments derived from 3-phenyl-benzopyrone (3-phenyl-chro-
mone) structure. They are found in plants mostly as biologically inactive glycosides: 7-O-β-
D-glycosides, 6″-O-acetyl-7-O-β-D-glucosides, and 6″-O-malonyl-7-O-β-D-glycosides [1, 2]. 
After ingestion, glycosides are not bioavailable to be absorbed through enterocytes [3]. They 
are hydrolyzed into bioactive aglycones by both intestinal mucosa and bacterial β-glucosidases 
from the gut microbiota. Only these forms are absorbed into systemic circulation directly or 
after subsequent metabolism in the bowel by intestinal bacteria [3]. Soybeans incorporate pre-
dominantly genistin, daidzin, and glycitin as inactive glycosides, which are hydrolyzed into 
their corresponding biologically active aglycones: genistein, daidzein, and glycitein. Other 
isoflavones observed in legumes are ononin and sissotrin, with their aglycones, formonone-
tin, and biochanin A, respectively (Figure 1).
The absorption of aglycones is fast and efficient. Plasmatic isoflavone levels increase up to 
micromolar-level values after the consumption of soy-based foods, compared to the nanomo-
lar (≤40 nm) levels found in diets without soy [4]. First pharmacokinetic study on isolated and 
purified isoflavones was performed, when a single dose of 50 mg of aglycone or the equiva-
lent dose of β-glycoside, respectively, was given to healthy adult volunteers. The plasmatic 
peak values (Cmax) were 341 ± 74 ng/mL for genistein and 194 ± 30.6 ng/mL for daidzein. The 
times when the values reached the peaks were 5.2 and 6.6 hours (tmax) in the case of direct 
aglycones ingestion and 9.3 and 9.0 h in the case of the ingestion of β-glycosides, genistin, and 
daidzin, due to the time required for their hydrolysation. The bioavailability of genistein and 
daidzein (based on the area under the curve in plasma concentration versus time graph) was 
higher after consumption of β-glycosides [5].
Formononetin and biochanin A can be transformed to daidzein and genistein, respectively, 
through 4′-O-demethylation by the gut microflora or in the liver [6]. Aglycones can be fur-
ther metabolized through several steps: reduction, deoxygenation, hydroxylation, and C-ring 
Superfood and Functional Food - The Development of Superfoods and Their Roles as Medicine134
cleavage. Daidzein forms S-(−)equol and O-desmethylangolensin (O-DMA) via dihydro-
daidzein (Figure 2). Similarly, genistein is metabolized first as dihydrogenistein and then 
as 5′-hydroxy-equol and p-ethyl phenol (Figure 2). Another possible minor pathway is the 
hydroxylation of isoflavone rings at different positions, catalyzed by hepatic cytochrome 
P450 isoenzymes [2]. Metabolites with phenolic or polyphenolic structures are conjugated 
to O-glucuronides and sulfate esters during and after absorption through the gut barrier and 
more intense in the liver. The conjugated metabolites are urinary or biliary excreted and have 
enterohepatic circulation [4, 7].
Gut microbiota play a very important role in the isoflavone metabolism. The positive effects of a 
soy-rich diet derive from the existence of microorganisms in the gut capable of intense metabo-
lization of isoflavones. It is the so-called equol producer phenotype, responsible for metaboliz-
ing daidzein to equol and identified through the equol/daidzein ratio in the 24-hour urine. Asian 
people (Japanese, Korean, or Chinese) and Western adult vegetarians are 50–60% equol produc-
ers, but equol producers are only 25–30% in Western population. This phenotype is rather stable 
and cannot be modulated through prebiotic or probiotic nutritional interventions [8]. Otherwise, 
there are differences between human and animal metabolism, and therefore in vivo results are 
not relevant to humans [9]. All tested animals had equol in urine after the ingestion of soy or 
clover [8]. Notably in rodents, equol constitutes 70–90% from the serum isoflavones, compared 
to humans where only 30% of the daidzein absorbed is metabolized as equol [4].
2.2. Isoflavone content in different sources
Isoflavones can be found in legumes [10–12], nuts, and some fruits, such as currants and rai-
sins [13], coffee [14], and cereals [15], but the most important dietary sources are soybeans and 
Figure 1. Chemical structure of main isoflavones.
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their by-products [10, 12]. The content of isoflavones in several plants and foods is presented 
in Tables 1 and 2. Soy can be ingested as textured soy protein, as soy milk or drink, added to 
many fortified foods (e.g., energized bars, cereals, baby formula), or consumed as fermented 
soybean products, such as miso, natto, and tempeh (Table 3) [12]. Also, many food supple-
ments containing soy isoflavones are on the market [16].
Isoflavone content in plants can vary greatly (up to threefold) for the same variety by growth 
conditions, geographical areas, years, biotic stress factors (e.g., pests), and abiotic stress fac-
tors, such as temperature, nutritional status, or drought [4]. Dietary culture has an especially 
Figure 2. Metabolic pathways of daidzein and genistein.
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Food description Daidzein Genistein Glycitein Total IFs
Soybeans, green, mature 
seeds, raw
61.70 60.07 7.07 128.83
Soybeans, mature seeds, 
raw (the mean values from 
Australia, Brazil, China, 
Europe, Japan, Korea, 
Taiwan, the USA)
62.07 (27.77–78.86) 80.99 (39.78–89.32) 14.99 (9.01–22.37) 154.53 (85.68–178.81)
Soybeans, mature seeds, 
cooked, boiled
30.76 31.26 3.75 65.11
Beans, common, raw 
(Phaseolus vulgaris)
0.29 0.30 0.00 0.59
Beans, adzuki, mature 
seeds, raw
0.36 0.23 0.00 0.59
Beans, pinto, mature seeds, 
raw
0.01 0.17 - 0.18
Black bean, sauce 5.96 4.04 0.53 10.26
Chickpeas, mature seeds, 
raw
0.21 0.06 0.18 0.38
Chickpeas, mature seeds, 
cooked, boiled
0.00 0.02 - 0.02
Peas, green, split, mature 
seeds, raw
0.32 0.11 0.00 0.44
Table 1. Isoflavone content in selected legumes (mg/100 g, edible portion—the mean value derived from multiple 
experiments) [12].
Food description Coumestrol Formononetin Biochanin A
Egg, whole, raw, fresh 0.00 0.05 0.05
Alfalfa seeds, sprouted, raw 1.60 1.43 0.04
Clover sprouts, raw 14.08 3.15 0.59
Red clover 1322.00 833.00 -
Soybeans, mature seeds, raw 0.02 8.46 0.00
Soybeans, mature seeds, sprouted, 
raw
0.34 0.03 0.00
Lima beans, large, mature seeds, raw 0.14 0.32 0.27
Lima beans, large, mature seeds, 
boiled
0.00 0.01 0.00
Chickpeas, mature seeds, raw 0.01 0.12 1.54
Chickpeas, mature seeds, canned 0.00 0.00 -
Table 2. Coumestrol, Formononetin, and Biochanin A in selected foods (mg/100 g, edible portion—the mean value 
derived from multiple experiments) [12].
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big influence on isoflavone content in the diet. Asian and vegetarian diets provide 20–50 mg 
isoflavones/day, in some cases reaching 100 mg/day, while the Western diet contributes only 
0.2–1.5 mg isoflavones/day [2]. Based on recent report of European Food Safety Authority 
(EFSA), in Europe the dietary isoflavone intake is usually under 1 mg/day, despite an increase 
in the soy food consumption [17]. The differences between the types of diets refer to the 
amount of isoflavone in foods, as well as the type of food consumed. In the Western diet, 
solid processed soy products (such as tofu) and soymilk dominate the diet, and they contain 
both glycosides (genistin and daidzin which are stable during processing) and aglycones. 
In the Asian diet, most soy products are obtained through fermentation and have higher 
amounts of aglycones [3]. Miso, fermented soybean paste (Japan); doenjang, fermented soy-
bean paste (Korea); douchi, fermented soybeans (China); and tempeh, fermented soybean 
cake (Indonesia) are staple foods in some Asian countries. Simultaneously, health benefit pro-
biotics are formed in these foods during the fermentation processes [18].
Food description Daidzein Genistein Glycitein Total IFs
Miso 16.43 23.24 3.00 41.45
Natto 33.22 37.66 10.55 82.29
Tempeh 22.66 36.15 3.82 60.61
Tofu, raw, regular, 
prepared with calcium 
sulfate
8.56 12.99 1.98 22.73
Soybeans, green, raw 
(includes edamame)
20.34 22.57 7.57 48.95
Soybeans, green, 
cooked, boiled, 
drained, without salt 
(includes edamame)
7.41 7.06 4.60 17.92
Soybeans, mature 
seeds, sprouted, raw
12.86 18.77 2.88 34.39
Instant beverage, 
soy, powder, not 
reconstituted
40.07 62.18 10.90 109.51
Soy cheese, unspecified 5.79 11.14 - 25.72
Soy drink 2.75 5.10 - 7.85
Soy flour (textured) 67.69 89.42 20.02 172.55
Soy meal, defatted, raw 80.77 114.71 16.12 209.58
Soy protein drink 27.98 42.91 10.76 81.65
Soy protein isolate 30.81 57.28 8.54 91.05
Soy yogurt 13.77 16.59 2.80 33.17
Table 3. Isoflavone content in soy foods (mg/100 g, edible portion—the mean value derived from multiple 
experiments) [12].
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Besides soy, other plants in the Fabaceae family have a high content of isoflavones: spe-
cies of clover, mainly red clover (Trifolium pratense L.), alfalfa (Medicago sativa L.), and hop 
clover (Medicago lupulina L.), form important part of animal feed. These plants are used in 
 phytotherapy, as medicinal teas or as food supplements. Red clover (Trifolium pratense L.) 
incorporates mainly genistein, daidzein and formononetin, and their respective β-glycosides 
[19–22]. It also contains important quantities of coumestrol, a phytoestrogen part of coumes-
tan class [19, 20], and antioxidant compounds [23, 24]. Data from scientific literature show 
that red clover extracts can be used as replacement for conventional hormonal therapy in 
menopause or hormone-dependent diseases [25]. Alfalfa (Medicago sativa L.) contains isofla-
vones (genistein, daidzein, formononetin, biochanin A) in addition to other phytoestrogens 
(coumestrol) and many nutrients. It is used in phytotherapy for its antianemic, antihemor-
rhagic, and remineralization properties [26] and for its hypocholesterolemic, antimicrobial, 
hypolipidemic, antioxidant, antiulcer, neuroprotective, and estrogenic properties [27]. Species 
of Genista (G. tinctoria L., G. sagittalis L.) contain essentially genistin and genistein [19, 20, 28, 
29]. They are known for their hypoglycemic [30], anti-inflammatory, antiulcer, spasmolytic, 
antioxidant, and estrogenic properties [31]. Among these plants, Genista tinctoria L. show anti-
oxidant and antitoxic activities [32, 33], protective effect against ultraviolet (UV) radiation, 
and in vitro melanoma cell proliferation [31].
2.3. Mechanism of estrogen-like action of isoflavones
According to the xenohormesis theory, plants synthesize phytochemicals to withstand and 
adapt under stress. Indeed, isoflavone biosynthesis depends on the environmental conditions 
in which the plant grows and is stimulated by stress. The stress-induced plant compounds 
have the ability to upregulate stress adaptive pathways in animals and humans. In the body, 
the biological effects of isoflavones are exercised by modulating pathways mediated by estro-
gen receptors (ERs) or various key enzymes involved in cellular signaling or metabolism and 
antioxidant potential [4].
3. The estrogenic/antiestrogenic effects
Isoflavones produce both estrogenic and antiestrogenic effects through several ways. Due to 
their structure similar to that of 17β-estradiol, they have the ability to bind to the nuclear ERs, 
but their affinity for these receptors is rather weak. Only genistein shows stronger affinity for 
ERβ to which it binds preferentially. Its relative affinity (0.87) is closer to that of the reference 
hormone, 17β-estradiol. Daidzein affinity for these receptors is 0.005, but equol, its metabolite, 
has a 5.7 times stronger affinity, thus increasing its estrogenic potential. The affinity for ERα 
decreases as follows: genistein > equol > daidzein, with the values of 0.04, 0.005, and 0.001, 
respectively. The affinities of other isoflavones are less than 0.0001 [2, 4].
Isoflavones induce agonist/antagonist effects depending on the level of the endogenous estro-
gen. For people with high levels of estrogen, (women premenopause, especially in the fol-
licular phase of the menstrual cycle), the isoflavones bind to the estrogen receptors. Because 
of their weak estrogen potency, isoflavones exert an antagonist effect. They block the action of 
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endogenous estrogens on their receptors. In case of low concentration of endogenous estro-
gens (women in menopause, after ovariectomy, or males), the estrogenic action of isoflavones 
becomes evident, showing additive agonist effect [34]. This is the reason why isoflavones can 
be used as a long-term complementary or alternative hormone therapy [35].
Isoflavones and their active metabolites can bind to the membrane ERs and induce rapid 
non-genomic effects by which they modulate cellular metabolism. Thus, they can change the 
protein kinase and lipid kinase cell signaling pathways [1]. It is believed that the activation 
of these signaling pathways by isoflavones causes some beneficial effects, in particular in the 
tissues that are not specific targets for the estrogens. At the circulatory system, the isoflavones 
induce vasodilation by increasing the production of nitric oxide (NO) after the activation of 
the endothelial NO− synthase. At the central nervous system, they improve the cognitive func-
tion by affecting cell membrane permeability and altering the neuronal excitability. In the 
skeletal system, the isoflavones inhibit the tyrosine kinase causing changes in the alkaline 
phosphatase activity. On the other hand, they induce the apoptosis of the osteoclasts, sup-
press the formation of osteoclasts [34], and prevent the bone demineralization [35].
Also, isoflavones influence the activity of some of the enzymes involved in the metabolism 
of the sex steroid hormones. In this way they inhibit 5α-reductase (the enzyme responsible 
for the conversion of testosterone to 5α-dihydrotestosterone) and aromatase (involved in the 
conversion of testosterone to estradiol) in low concentrations, but they increase the aromatase 
activity at high concentrations. Isoflavones have an affinity for sex hormone-binding globulin 
(SHBG) and they induce its expression. Therefore, they affect the free-steroid hormone level 
in the systemic circulation. But these outcomes depend on many factors, including species, 
gender, and the hormonal status [35].
Xenoestrogens can modulate the enzyme activity of aromatase. Thus, they induce alterations 
in the metabolism of fats and carbohydrates through effects on ERα. The decrease of endog-
enous estrogen levels on ERα, aromatase inhibition or the existence of mutations affecting 
the enzyme activity has been correlated with visceral obesity or truncate, hyperlipidemia, 
glucose intolerance and insulin resistance, low physical activity, and reduced energy expen-
diture. Isoflavones compensate for the deficit of estrogens and have the ability to prevent the 
associated negative effects. Asian diets, rich in isoflavones, are correlated with low incidence 
of obesity and metabolic syndrome, favorable plasma profile, and a reduced body mass index 
in postmenopausal women [4].
4. Health benefits of isoflavones
4.1. Isoflavones and their effects on diseases
Numerous epidemiological and clinical studies have demonstrated the protective role of 
dietary isoflavones against development of specific menopause symptoms [36–38] and sev-
eral chronic diseases, including cardiovascular diseases [39, 40], osteoporosis [38], cognitive 
impairment [37], and hormone-dependent cancers [41–43]. Based on human health benefits of 
soy diet, the Food and Drug Administration (FDA) approved the use of the following health 
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claim on the labels: “25 grams of soy protein a day, as part of a low in saturated fat and cho-
lesterol, may reduce the risk of heart disease” [44].
Isoflavones, as all polyphenols, have a strong antioxidant activity. They can neutralize free 
radicals and prevent the lipid peroxydation by stopping the chain reactions. Also, isoflavones 
induce the antioxidant enzymes (glutathione peroxidase, catalase, and superoxide dismutase) 
and inhibit the expression of some enzymes, such as xanthine oxidase [1]. The antioxidant 
protective action of isoflavones from soy or plant extracts, such as Trifolium pratense L. or 
Genista tinctoria L., was proven in clinical studies [45, 46], as well as in animal models [32, 47].
4.2. Anticarcinogenic activity of isoflavones
The anticarcinogenic potential of isoflavones is based on multiple actions: binding to estro-
gen receptors (ERs), changing of cell signaling pathways, and inhibition of the key enzymes 
involved in the metabolism of sex hormones. Also, the anticarcinogenic potential of iso-
flavones has positive effects through independent mechanisms which do not involve ERs, 
such as antioxidant activity, reduction in the bioactivation of carcinogens, and stimulation of 
detoxification [2, 48].
Anticarcinogenic activity of genistein has been assessed more thoroughly among isofla-
vones. Genistein initiates apoptosis, alters cell proliferation and angiogenesis, and inhibits 
metastasis in many types of cancer cells [49]. It is a tyrosine kinase inhibitor. Therefore, in 
breast cancer cells, it slows down tumorigenesis; in the circulatory system, it prevents tumor 
vascularization; in the nervous system, it induces neuroprotective effects. In addition, genis-
tein affects tumorigenesis by inhibiting DNA topoisomerases I and II [50], alteration of epi-
genetic regulations (both histone methylation and DNA methylation), and activating tumor 
suppressor genes [51]. As a polyphenol, genistein has antioxidant [1] and anti-inflammatory 
potential [52]. Another possible action pathway for genistein is the competitive inhibition of 
estrone metabolism through cytochrome P450 isoenzymes by altering the 2-hydroxy-estrone 
(2-OH-E1)/16α-hydroxy-estrone (16α-OH-E1) ratio, as noticed in vitro [53]. While 2-OH-E1 is a weak estrogen, 16α-OH-E1 has an important role in carcinogenesis, showing a strong estrogen effect and genotoxic properties [54]. 16α-OH-E1 covalently binds to the estrogenic receptors 
and thus stimulates cell proliferation [55]. The ratio 2-OH-E1/16α-OH-E1 has been proposed and studied as a biomarker of breast cancer risk [55–59], but now its significance is controver-
sial. In high concentrations, genistein decreases the hydroxylation of estrone in position 2 in 
favor of hydroxylation in position 16α [55]. Other studies show that genistein has no muta-
genic or clastogenic activity in vivo. But in high concentration of genistein, it has clastogenic 
potential in vitro, explained by the topoisomerase inhibitory effect, which is known to cause 
chromosome damage above a certain threshold dose [60].
Anti-proliferative effects of high concentrations of genistein were demonstrated in all breast 
cancer cells, both ER positive and ER negative. However, there are several studies showing 
that genistein shows both anti-proliferative and proliferative effects, depending on the con-
centration, type of tumor, level of endogenous estrogens present in the tissue, or development 
stage. At low physiological concentrations, genistein stimulates tumorigenesis and cancels the 
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effects of tamoxifen in ER-positive breast cancer cells [50]. Similar dual effects were observed 
in the case of tamoxifen and other selective estrogen receptor modulators (SERMs) [16].
In fermented soybean products (e.g., natto, miso, tempeh), aglycons can suffer changes under 
the effect of enzymes produced by the microorganisms involved in the fermentation process. 
Thus, ortho-hydroxygenistein (6-OHG, 8-OHG, 3′-OHG) and ortho-hydroxydaidzein (6-OHD, 
8-OHD, 3′-OHD) were identified. These compounds are not synthesized by the plants. The 
hydroxylation reaction that occurs in the ortho position gives molecules a high antioxidant 
potential and a free radical scavenging activity. Moreover, several of their abilities have been 
proven: to suppress cell proliferation and to inhibit tyrosinase (anti-melanogenesis proper-
ties) and antimutagenic, anti-inflammatory, and hepatoprotective properties [18].
Equol has a higher estrogenic potential than daidzein, its precursor, and a preferential affin-
ity for ERβ, as it has already been stated. This detail is of high interest for its beneficial effect 
in the treatment of prostate cancer, since both isomers, S-(−)equol and R-(+)equol, can bind 
in vivo dihydrotestosterone without having an affinity for the androgen receptor. Therefore, 
equol prevents the endogenous hormone to exert its stimulating effect on prostate growth. In 
addition, equol possesses the highest antioxidant capacity of all isoflavones tested. It causes 
blood vessel relaxation and modifies the inflammatory response in activated macrophages 
and has beneficial effects in cardiovascular and inflammatory diseases [52].
4.3. Effects of isoflavones on hormone-dependent cancers
Clinical studies show contradictory results of the efficacy of isoflavones in the treatment of 
breast cancer. The effects depend on a number of factors such as age, gender, hormonal status, 
type of isoflavones consumed (soy proteins or isolated isoflavones), dose, diet (type of food), 
and extent of consumption [2].
A recent meta-analysis of 35 studies shows that soy isoflavones lower the risk of breast cancer 
in both premenopausal and post-menopausal women. The effect is more evident in Asian 
women than in those living in Western countries, probably due to differences in quality (tra-
ditionally fermented foods) and quantity of the isoflavone products ingested [41]. In Asian 
women, a diet rich in soy food lowers breast cancer risk with 30% [61]. A higher prevalence 
of equol-producer phenotype in Asian population can be an essential factor. Equol-producer 
phenotype is associated with a substantial reduction in the risk of breast cancer. Several spe-
cific biomarkers are favorable modified, such as sex hormone-binding globulin (SHBG) and 
steroid hormone levels in plasma, a higher urinary 2-hydroxy-estrone/16α-hydroxy-estrone 
ratio, and a lower mammographic breast density [2]. However, because several studies have 
provided mixed or contradictory results, the general recommendation for patients diagnosed 
with estrogen-dependent breast cancer is to avoid consuming high quantities of products con-
taining isoflavone. Indeed, isoflavones are selective estrogen receptor modulators (SERMs), 
and their effects would depend on multiple factors.
Another meta-analysis of five cohort studies that included more than 11,000 female patients 
diagnosed with breast cancer focused on the post-diagnostic relationship between consump-
tion of soy foods and mortality or cancer recurrence. The study concluded that the ingestion 
Superfood and Functional Food - The Development of Superfoods and Their Roles as Medicine142
of soy foods reduced mortality and recurrence in all types of breast cancer, especially in the 
ER-negative, ER-positive/PR-positive, and postmenopausal patients [42]. In women diag-
nosed with breast cancer under tamoxifen treatment, the consumption of plants containing 
isoflavones did not alter plasma levels of the drug and its metabolites [62]. Moreover, a recent 
study shows that a moderate intake of soy isoflavones (5–10 g soy protein/day) would have 
an optimal effect on tamoxifen treatment on these patients [63].
In some studies [64], excessive consumption of soy was associated with a negative impact on 
male fertility and reproductive hormones and the disruption of the thyroid gland function. In 
other studies these effects were inconsistent [65].
Isoflavones can modulate the toxicity of other xenoestrogens, but the interactions are complex 
and difficult to predict relying only on in vitro steroid receptor affinities [66]. In these kinds of 
interactions, multiple mechanisms are involved, both estrogen and non-estrogen type, such 
as oxidative stress [32, 47, 53]. European Food Safety Authority (EFSA) has recently conducted 
a systematic study of published medical literature, focusing on the correlation between the 
intake of soy isoflavones and the induced effects on the breast (mammographic density, pro-
liferative marker Ki67 expression), uterus (endometrial thickness, histopathology changes), 
and thyroid (the thyroid hormone). Results showed that the intake of 35–150 mg isoflavones/
day does not affect these organs in peri- and postmenopausal women [17]. Isoflavones have 
demonstrated prostate cancer efficacy in several studies: in vitro, on prostate cancer cell lines, 
in vivo, and in numerous clinical trials [43, 67, 68]. Conclusion of a recent meta-analysis sug-
gests that phytoestrogen intake, mostly genistein and daidzein, can be correlated with a 
decreased risk of prostate cancer [69].
5. Recent advances in analytical methods of isoflavones
5.1. Isolation of isoflavones in foods and vegetable materials
In recent years, due to the health benefits provided by isoflavones, higher attention has been 
paid to the analytical methods that allow identification and quantification of isoflavones from 
different types of samples: (a) food, for dietary intake assessing [15, 70]; (b) food supplements, 
for standardization of nutraceuticals [5, 71]; (c) vegetable products, for phytotherapeutic eval-
uation [19, 20, 28]; and (d) human biological samples (plasma, urine) [5]. These analytical 
methods are commonly used for isoflavone bioavailability assessing and in pharmacokinetic 
or pharmacological studies.
Isoflavones are solubilized from food or vegetable material by refluxing or maceration, shak-
ing, and stirring [72]. The isolation of isoflavones from the mixture can be achieved either by 
conventional methods, liquid-liquid extraction [11, 15, 19] or Soxhlet, or by modern ones—
supercritical fluid extraction, ultrasound-assisted extraction [19, 71], pressurized fluid extrac-
tion, microwave-assisted extraction, and solid-phase extraction [5, 73] (Table 4).
The methods used to isolate isoflavones from food are selected function of the nature of 
the food, the type of the isoflavones analyzed (the total of aglycones or aglycones and 
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 glycosides), and the instrumental method used for identification and quantification. Several 
examples are presented below.
Liggins et al. isolated isoflavones from cereals and derivatives after a prior sonication in a polar 
solvent (methanol/water 4:1, v/v), in order to break apart the cellular material, followed by fil-
tration and evaporation of the solvent under nitrogen. In order to determine the total aglycones, 
glycosides were hydrolyzed in an acid medium (0.1 M acetate buffer, pH 5) by overnight incu-
bation at 37 °C in the presence of cellulase (enzyme used for hydrolytic removal of the hydroly-
sis resulted carbohydrates). Aglycones were extracted into ethyl acetate and were derivatized 
and analyzed using GC-MS [15]. Otieno et al. analyzed isoflavones from fermented and unfer-
mented soy milk. For the solubilization of analytes, the freeze-dried sample was refluxed in 
methanol for 1 hour and filtered, and after adding the internal standard, the solvent has been 
evaporated to dryness under nitrogen. The residue has been suspended into a buffer (10 mm 
ammonium acetate containing 0.1% trifluoroacetic acid) and centrifuged, and the supernatant 
was filtered and analyzed using high-performance liquid chromatography (HPLC) [74].
Extraction and analysis of isoflavones in soybeans can be realized through maceration of the 
powdered beans with 70% ethanol at room temperature, for 24 hours under constant stirring. 
Analytes Sample Extraction 
method
Detection Run time (min) LOQ References
3 IFs Soy dry extract Sonication/
Steam bath
HPLC-DAD 20 40–100 ng/mL [71]
3 IFs, Cou* 10 plant species UAE** ULPC-PDA 4 1.97–4.08 ng/mL [19]
12 IFs Soybean seeds Maceration HPLC-UV 60 NA# [70]
12 IFs Soybeans, soy 
products
Maceration HPLC-DAD 30 <600 nmol/L [72]
3 IFs Coffee Refluxing HPLC-DAD 35 13.7–25.0 ng/mL [14]
17 IFs Soymilk Refluxing LC-ESI(+)-MS/
MS
NA# NA# [74]
7 IFs, Cou* 2 plant extracts Refluxing or 
Maceration
LC-ESI(−)-MS/
MS
18 40 ng/mL [20]
5 IFs, Cou* 7 plant extracts Maceration or 
percolation
ULPC-
ESI(+)-MS/
MS
5.5 5–10.78 ng/mL [28]
5 IFs Legumes SPE C18 UHLPC-
ESI(+)-MS/
MS
18 0.1–1 ng/mL [73]
5 IFs Coffee SPE C18 HPLC-ESI-MS/
MS
18 0.05–1 ng/mL [75]
* Cou, coumestrol.
** UAE, ultrasound-assisted extraction.
# NA, not available.
Table 4. HPLC and UPLC methods applied for analysis of isoflavones in different samples.
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After centrifugation and filtering, the supernatant is analyzed directly by HPLC [70]. Also, 
analysis of isoflavones contained in food supplements requires a simple preparation of the 
samples: fine powdering of tablets, refluxing in 80% methanol for 1 hour, filtering, and injec-
tion into the HPLC system [5].
Hydroalcoholic extracts or tinctures can be prepared from either fresh or dry and pulverized 
vegetable materials. The hydroalcoholic extracts can be made in 70% ethanol or methanol, by 
refluxing and filtration; by cold maceration, pressing, and filtration [20]; by percolation [28]; 
or using modern methods, such as ultrasound-assisted extraction in 50% ethanol [19]. The 
extracts can be analyzed directly by LC-MS/MS, after an adequate dilution [20], or they can be 
subjected to an acid hydrolysis [19] in order to release aglycones. Further, the aglycones can 
be assessed directly or after liquid-liquid extraction, for a concentration of the analytes [19].
In biological samples (e.g., plasma and human urine) isoflavones can be found in different 
forms: as aglycones (active metabolites), aglycone derivatives (with or without bioactivity), 
or conjugated metabolites (β-glucuronides and sulfate esters). Isoflavone analysis can focus 
on individual quantification of aglycones and their metabolites or quantification of aglycones 
after the hydrolysis of conjugated forms. Hydrolysis of conjugated metabolites is achieved 
by incubation at 37 °C with a mixture of β-glucuronidase/sulfatase in the presence of a buffer 
(0.5 M acetate) at pH 4.5 for several hours or overnight. Isolation of free forms and/or of those 
freed after hydrolysis can be done by liquid-liquid extraction or solid-phase extraction [5].
5.2. Quantification of isoflavones in foods and vegetable materials
For isoflavone identification, the following chromatographic methods are used: gas chroma-
tography coupled with mass spectrometry (GC-MS) [5, 15], high-performance liquid chro-
matography (HPLC) with UV detector (photodiode array, PDA) [28, 70, 71], fluorescence 
detector (FLD), electrochemical detector (ECD) or mass spectrometer detector (MS) [20, 74, 
75], and, less often, capillary electrophoresis (CE).
Quantification of isoflavones and their derivatives can be achieved in two ways: (a) by deter-
mining the free aglycons after a prior acid hydrolysis [19, 70, 72], alkaline hydrolysis [72], or 
enzymatic hydrolysis [72] of the glycosides in the sample and (b) by simultaneously analyz-
ing the glycosides and aglycones present in the sample [20, 28]. GC-MS methods are used 
less lately, because they require an additional step of isoflavone derivatization to the volatile 
compounds [5, 15]. This additional step increases both the time and the cost of the analysis 
and represents a potential source of error [28].
Generally, HPLC-UV is not sensitive enough (Table 4) for the quantification of small levels 
of isoflavones from plant extracts [19] or human plasma [5]. This method often requires a 
hydrolysis step to transform glycosides into aglycones followed by the quantification of total 
aglycones from the sample [71].
In order to correctly identify new isoflavones or isoflavone derivatives present in the samples 
analyzed, liquid chromatography coupled with mass spectrometry (LC-MS) and tandem mass 
spectrometry (LC-MS/MS) are the preferred methods (Table 4), due to the advantages: speed, 
selectivity, sensitivity, and robustness. In addition, mass spectrometry detection allows sure 
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determination of the compounds based on molecular weight and ion charge. For the quanti-
fication of isoflavones, the pseudo-molecular ions or the ionic fragments resulted after frag-
mentation are monitored. In LC-MS/MS analysis, compound identification can be achieved 
even if their separation is not complete, and it is an advantage [74]. A shorter analysis can 
be realized by ultra-performance liquid chromatography (UPLC) [19, 28]. This method uses 
columns with very small size of the packing particles (1.7 μm) and consequently performs 
separations with superior resolution in a shorter time and a lower consumption of the mobile 
phase.
The isoflavones have polyphenolic structure and can easily lose a proton to form negative 
pseudo-molecular ions [M-H]− [20]. However, they can also be detected after ionization in 
positive mode to [M + H]+ [74]. Isoflavones are polar compounds and they form ions in solu-
tion. For these type of compounds, electro-spray ionization (ESI) is the most commonly used 
source to obtain analytical ions. Atmospheric pressure chemical ionization (APCI) is the 
source preferred for non-polar analytes that ionize in the gas phase. The isoflavones often give 
poor response in this ionization source [28]. The fragmentation patterns of isoflavone glyco-
sides (malonyl-glycosides, acetyl-glycosides, glycosides, aglycones) follow a similar trend. 
However each compound has a unique fragmentation pattern that allows their accurate iden-
tification (Table 5) [74].
Isoflavone [M + H]+ Transitions [M − H]− Tranzitions
Daidzein 255 [28, 74] →199 [28] 253 [20, 73, 75] →208, 132 [73, 75]
Formononetin 269 [28] →197 [28] 267 [20, 75] →252, 223 [75]
Genistein 271 [28, 73, 74] →153 [28] 269 [20, 73, 75] →159, 133 [73, 75]
Biochanin A 283 [73, 75] →268, 239 [73, 75]
Glycitein 285 [74] →270, 257, 229, 196, 
166 [74]
283 [20]
Daidzin 417 [28, 73, 74] →255 [28, 73, 74], 199 
[73]
415 [20] →253 [20]
Ononin 429 [20] →267 [20]
Genistin 433 [28, 74, 75] →271 [28, 73–75], 91 
[73, 75]
431 [20] →268, 269 [20]
Glycitin 447 [74] →428, 285 [74]
Ac-daidzin 459 [74] →441, 255 [74]
Ac-genistin 475 [74] →431, 271 [74]
Ac-glycitin 489 [74] →471, 285 [74]
Mal-daidzin 503 [74] →485, 255 [74]
Mal-genistin 519 [74] →501, 271 [74]
Table 5. Ions (m/z) and transitions monitored for isoflavone quantification.
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6. Conclusion
Dietary intake of isoflavones is widespread, mainly due to the high consumption of soybean 
products. Health benefits of isoflavones justify the interest for this class of bioactive com-
pounds, but the controversial outcomes of some clinical and epidemiological studies require 
further investigations. In the context of these researches, the analytical methods applied for 
assessment of isoflavones are very valuable. They allow for the evaluation of dietary intake of 
isoflavones, equating the health benefits and the circumstances in which they are exerted, and 
highlight the natural sources of isoflavones with phytotherapeutic potential.
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